Yamamoto Tetsuji, Akisue Toshihiro, Marui Takashi, Fujita Ikuo, Matsumoto Keiji, Hitora Toshiaki, Kawamoto Teruya, Nagira Keiko, Nakatani Tetsuya, Kurosaka Masahiro
Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Clin Cancer Res. 2004 Sep 1;10(17):5804-7. doi: 10.1158/1078-0432.CCR-0770-03.
Transforming growth factor beta (TGF-beta) is a multifunctional growth factor that variably affects proliferation, differentiation, and extracellular matrix formation. Little information is currently available on the TGF-beta expression in malignant fibrous histiocytoma (MFH). The aims of the present study were to investigate the expression of TGF-beta isoforms and their receptors in human MFH specimens.
The expression of TGF isoforms, and TGF-beta receptors (TGF-beta R1 and -beta R2) were immunohistochemically evaluated in 43 paraffin-embedded MFH specimens. Furthermore, the correlation of the TGF-beta and receptor expression with tumor proliferative activity assessed by MIB-1 indices was analyzed.
Positive immunoreactivity for TGF-beta1, -beta2, and -beta 3 was identified in tumor cells of 42, 40, and 38 of the 43 MFHs, respectively. In each TGF-beta isoform immunostaining, the specimens were divided into two groups based on the number of positive tumor cells: those with low (<25%) and those with high (>==25%) immunoreactivity. There were no statistically significant differences in the MIB-1 indices between the two groups. Positive immunoreactivity for TGF-beta R1 and -beta R2 was identified in tumor cells of 36 and 24 of the MFHs, respectively. The specimens were divided into two groups based on their receptor expression patterns: those with both TGF-beta R1- and -beta R2-positive immunoreactivity (n = 23), and those with both or either TGF-beta R1- and -beta R2-negative immunoreactivity (n = 20). The MIB-1 indices in the both-TGF-beta R1- and -beta R2-positive group were significantly higher than those in the other group (P = 0.0102). There was no significant difference in pulmonary metastasis ratios between the two groups.
These findings strongly suggest an association of the TGF-beta ligand/receptor system with a significantly higher MIB-1 index in human MFHs. Investigation of the TGF-beta R1 and -beta R2 coexpression might be useful in predicting tumor behavior of MFHs.
转化生长因子β(TGF-β)是一种多功能生长因子,对细胞增殖、分化及细胞外基质形成具有多种影响。目前关于恶性纤维组织细胞瘤(MFH)中TGF-β表达的信息较少。本研究旨在探讨TGF-β亚型及其受体在人MFH标本中的表达情况。
采用免疫组织化学方法评估43例石蜡包埋的MFH标本中TGF-β亚型及TGF-β受体(TGF-βR1和-βR2)的表达。此外,分析TGF-β及其受体表达与通过MIB-1指数评估的肿瘤增殖活性之间的相关性。
在43例MFH中,分别有42例、40例和38例肿瘤细胞中TGF-β1、-β2和-β3免疫反应呈阳性。在每种TGF-β亚型免疫染色中,根据阳性肿瘤细胞数量将标本分为两组:低免疫反应性组(<25%)和高免疫反应性组(>=25%)。两组之间的MIB-1指数无统计学显著差异。在MFH的肿瘤细胞中,分别有36例和24例TGF-βR1和-βR2免疫反应呈阳性。根据受体表达模式将标本分为两组:TGF-βR1和-βR2免疫反应均为阳性组(n = 23),以及TGF-βR1和-βR2免疫反应均为阴性或任一为阴性组(n = 20)。TGF-βR1和-βR2均为阳性组的MIB-1指数显著高于另一组(P = 0.0102)。两组之间的肺转移率无显著差异。
这些发现强烈提示TGF-β配体/受体系统与人MFH中显著更高的MIB-1指数相关。研究TGF-βR1和-βR2的共表达可能有助于预测MFH的肿瘤行为。